Xenobiotic-responsive hepatic long non-coding RNAs
异生素反应性肝脏长非编码RNA
基本信息
- 批准号:10809269
- 负责人:
- 金额:$ 7.78万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-08-15 至 2025-04-30
- 项目状态:未结题
- 来源:
- 关键词:AbbreviationsAddressAdultAffectAgonistArchitectureAutomobile DrivingBenzeneBiologicalCRISPR interferenceCellsChemical ExposureChemicalsChromatinChromatin LoopCirrhosisClustered Regularly Interspaced Short Palindromic RepeatsCodeComplexDeoxyribonucleasesDependovirusDevelopmentDiagnosisDietDiseaseDisease ProgressionEnvironmentEnvironmental PollutantsEnzymesEpigenetic ProcessEtiologyEvaluationEventExposure toFatty LiverGene ExpressionGene Expression ProfileGene TargetingGenesGenetic TranscriptionGenomeGenomicsGuide RNAHealthHepaticHepatic lobuleHepatocyteHigh Fat DietHumanIndustrializationInflammationKnock-outLigandsLinkLiverLiver CirrhosisLiver FailureLiver diseasesLobuleMediatorMetabolic PathwayMetabolismMitochondriaModelingMusNuclearNuclear Pore ComplexNuclear ReceptorsOrthologous GenePPAR alphaPathologicPathologyPathway AnalysisPathway interactionsPhysiological ProcessesPositioning AttributePrimary carcinoma of the liver cellsProcessProteinsReceptor ActivationRegulator GenesResearchRoleSerotypingSiteSpecificityTestingTimeTissuesUntranslated RNAWorkXenobiotic MetabolismXenobioticsadvanced diseaseblood glucose regulationcarbohydrate metabolismcell typeconstitutive androstane receptorendonucleaseenvironmental chemicalenvironmental chemical exposurefatty liver diseasegene networkgene regulatory networkgene repressionin vivoinsightinterestlipid biosynthesislipid metabolismliver developmentliver metabolismmouse modelnon-alcoholic fatty liver diseasenonalcoholic steatohepatitisnovel markerpregnane X receptorpreventprogramspromoterprototypereceptorsingle nucleus RNA-sequencingtherapeutic targettranscription factortranscription terminationtranscriptometranscriptomic profiling
项目摘要
7. Project Summary/Abstract
Many industrial chemicals, environmental pollutants and other xenochemicals activate transcription factors
belonging to the nuclear receptor superfamily, which leads to widespread genomic, epigenetic and
transcriptional changes that disrupt key biological pathways and metabolic processes in liver and other
tissues. The studies proposed focus on the liver nuclear receptor CAR (Constitutive Androstane Receptor;
NR1I3), which is activated by structurally diverse xenochemicals and regulates transcription of hundreds of
protein-coding genes important for processes such as xenobiotic metabolism, lipogenesis, glucose
homeostasis, and inflammation, and has been implicated as a regulator of non-alcoholic fatty liver disease
(NAFLD) development. We have discovered that xenobiotic agonists of CAR and other xenobiotic-responsive
receptors induce or repress the transcription of several hundred nuclear-enriched long non-coding RNAs
(lncRNAs) with epigenetic and gene regulatory potential, many of which have human orthologs. This proposal
builds on these findings and on recent advances in liver cell zonation, single cell-based transcriptomic
profiling, and gene co-expression network analysis to elucidate in an intact mouse liver model the effects of
CAR-responsive lncRNAs on fatty liver disease induced by foreign chemical exposure. The studies proposed
test the hypothesis that a subset of CAR-responsive lncRNAs control hepatic gene regulatory networks driving
NAFLD and downstream pathologies, dysregulating processes such as lipid and carbohydrate metabolism,
hepatic architecture and mitochondrial function in a liver cell type-specific and hepatic lobule zone-dependent
manner. The work proposed uses TCPOBOP (1,4-bis[2-(3,5-dichloro-pyridyloxy)]benzene), a prototypic non-
genotoxic chemical and CAR-specific agonist ligand, to address the seemingly paradoxical finding that
persistent exposure to foreign chemical CAR activators induces NAFLD in mice fed normal chow diet, but
suppresses NAFLD development in mice fed a high fat diet. These studies will elucidate the role of CAR, and
the lncRNAs that it regulates, in fatty liver disease etiology and progression. Results obtained will give critical
insight into the underlying mechanisms by which foreign chemicals dysregulate CAR-dependent metabolic
pathways linked to NAFLD, which affects 25% of US adults and is a major cause of cirrhosis, hepatocellular
cancer and liver failure. This work will refocus research efforts on xenochemical action to include mechanistic
studies of single cell-based, spatially zonated gene regulatory networks and the non-coding transcriptome,
and will serve as a paradigm for other foreign chemical-activated receptors that dysregulate gene expression
in complex ways. Together, the proposed studies on CAR-responsive lncRNAs and their role in xenochemical-
induced liver pathology may lead to new ways to prevent, diagnose or treat liver diseases induced by chemical
exposure.
7. 项目总结/文摘
项目成果
期刊论文数量(15)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Chemical and Hormonal Effects on STAT5b-Dependent Sexual Dimorphism of the Liver Transcriptome.
- DOI:10.1371/journal.pone.0150284
- 发表时间:2016
- 期刊:
- 影响因子:3.7
- 作者:Oshida K;Waxman DJ;Corton JC
- 通讯作者:Corton JC
Impact of Neonatal Activation of Nuclear Receptor CAR (Nr1i3) on Cyp2 Gene Expression in Adult Mouse Liver.
新生儿核受体 CAR (Nr1i3) 激活对成年小鼠肝脏 Cyp2 基因表达的影响。
- DOI:10.1093/toxsci/kfac032
- 发表时间:2022
- 期刊:
- 影响因子:0
- 作者:Shin,Aram;Waxman,DavidJ
- 通讯作者:Waxman,DavidJ
Long non-coding RNA G23Rik attenuates fasting-induced lipid accumulation in mouse liver.
- DOI:10.1016/j.mce.2022.111722
- 发表时间:2022-11-01
- 期刊:
- 影响因子:4.1
- 作者:Kim, Donghwan;Kim, Bora;Brocker, Chad N.;Karri, Kritika;Waxman, David J.;Gonzalez, Frank J.
- 通讯作者:Gonzalez, Frank J.
Global analysis of expression, maturation and subcellular localization of mouse liver transcriptome identifies novel sex-biased and TCPOBOP-responsive long non-coding RNAs.
- DOI:10.1186/s12864-021-07478-5
- 发表时间:2021-03-24
- 期刊:
- 影响因子:4.4
- 作者:Goldfarb CN;Waxman DJ
- 通讯作者:Waxman DJ
Long non-coding RNA Gm15441 attenuates hepatic inflammasome activation in response to PPARA agonism and fasting.
- DOI:10.1038/s41467-020-19554-7
- 发表时间:2020-11-17
- 期刊:
- 影响因子:16.6
- 作者:Brocker CN;Kim D;Melia T;Karri K;Velenosi TJ;Takahashi S;Aibara D;Bonzo JA;Levi M;Waxman DJ;Gonzalez FJ
- 通讯作者:Gonzalez FJ
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DAVID J WAXMAN其他文献
DAVID J WAXMAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DAVID J WAXMAN', 18)}}的其他基金
Xenobiotic-responsive hepatic long non-coding RNAs
异生素反应性肝脏长非编码RNA
- 批准号:
10711162 - 财政年份:2022
- 资助金额:
$ 7.78万 - 项目类别:
Growth Hormone Regulation of Sex Differences in Liver Metabolism
生长激素对肝脏代谢性别差异的调节
- 批准号:
9897015 - 财政年份:2019
- 资助金额:
$ 7.78万 - 项目类别:
Growth Hormone Regulation of Sex Differences in Liver Metabolism
生长激素对肝脏代谢性别差异的调节
- 批准号:
10626011 - 财政年份:2019
- 资助金额:
$ 7.78万 - 项目类别:
Growth Hormone Regulation of Sex Differences in Liver Metabolism
生长激素对肝脏代谢性别差异的调节
- 批准号:
10402862 - 财政年份:2019
- 资助金额:
$ 7.78万 - 项目类别:
Growth Hormone Regulation of Sex Differences in Liver Metabolism
生长激素对肝脏代谢性别差异的调节
- 批准号:
10164773 - 财政年份:2019
- 资助金额:
$ 7.78万 - 项目类别:
Growth Hormone Regulation of Sex Differences in Liver Metabolism
生长激素对肝脏代谢性别差异的调节
- 批准号:
10018890 - 财政年份:2019
- 资助金额:
$ 7.78万 - 项目类别:
Xenobiotic-responsive hepatic long non-coding RNAs
异生素反应性肝脏长非编码RNA
- 批准号:
10615645 - 财政年份:2014
- 资助金额:
$ 7.78万 - 项目类别:
Xenobiotic-responsive hepatic long non-coding RNAs
异生素反应性肝脏长非编码RNA
- 批准号:
10394387 - 财政年份:2014
- 资助金额:
$ 7.78万 - 项目类别:
Xenobiotic-responsive hepatic long non-coding RNAs
异生素反应性肝脏长非编码RNA
- 批准号:
10210396 - 财政年份:2014
- 资助金额:
$ 7.78万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 7.78万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 7.78万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 7.78万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 7.78万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 7.78万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 7.78万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 7.78万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 7.78万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 7.78万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 7.78万 - 项目类别:
Research Grant